Opaleye Management

Opaleye Management as of Sept. 30, 2017

Portfolio Holdings for Opaleye Management

Opaleye Management holds 34 positions in its portfolio as reported in the September 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Blueprint Medicines (BPMC) 18.1 $51M 735k 69.67
Axogen (AXGN) 13.5 $38M 2.0M 19.35
Fibrogen (FGEN) 6.8 $19M 360k 53.80
Immunomedics 4.4 $13M 899k 13.98
Loxo Oncology 4.2 $12M 130k 92.12
Codexis (CDXS) 4.0 $11M 1.7M 6.65
Corium Intl 3.6 $10M 920k 11.08
Momenta Pharmaceuticals 3.3 $9.3M 500k 18.50
Sangamo Biosciences (SGMO) 3.1 $8.7M 580k 15.00
Agios Pharmaceuticals (AGIO) 3.1 $8.7M 130k 66.75
Cytomx Therapeutics (CTMX) 2.9 $8.2M 450k 18.17
Strongbridge Bioph shs usd 2.9 $8.1M 1.2M 6.90
Eagle Pharmaceuticals (EGRX) 2.7 $7.8M 130k 59.64
Chimerix (CMRX) 2.6 $7.4M 1.4M 5.25
Foamix Pharmaceuticals 2.2 $6.3M 1.1M 5.55
Xoma Corp Del (XOMA) 2.2 $6.3M 320k 19.65
Theravance Biopharma (TBPH) 2.2 $6.2M 180k 34.24
Cymabay Therapeutics 1.9 $5.4M 665k 8.05
Audentes Therapeutics 1.8 $5.0M 180k 28.01
Synlogic 1.7 $4.8M 250k 19.01
Enanta Pharmaceuticals (ENTA) 1.7 $4.7M 100k 46.80
Deciphera Pharmaceuticals (DCPH) 1.5 $4.1M 217k 18.99
Ardelyx (ARDX) 1.4 $3.9M 700k 5.60
Acceleron Pharma 1.3 $3.8M 102k 37.32
Insmed (INSM) 1.3 $3.7M 120k 31.21
Inotek Pharmaceuticals 1.1 $3.2M 1.8M 1.78
Neuroderm Ltd F 1.0 $2.7M 70k 38.90
Aratana Therapeutics 0.9 $2.6M 420k 6.13
Selecta Biosciences (RNAC) 0.6 $1.7M 95k 18.24
Syros Pharmaceuticals 0.6 $1.7M 117k 14.72
Intercept Pharmaceuticals In 0.6 $1.6M 28k 58.03
ArQule 0.5 $1.4M 1.2M 1.11
Quotient Technology 0.2 $542k 110k 4.93
Biolinerx Ltd-spons 0.1 $280k 250k 1.12